• FirefoxInstall the new Firefox »
  •  Dow Up1.45% Nasdaq Up0.72%

    Uroplasty, Inc. (UPI)

    1.30 Down 0.00(0.01%) 10:28AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    Uroplasty, Inc.
    5420 Feltl Road
    Minnetonka, MN 55343
    United States - Map
    Phone: 952-426-6140
    Fax: 952-426-6199
    Website: http://www.uroplasty.com

    Index Membership:N/A
    Industry:Medical Appliances & Equipment
    Full Time Employees:113

    Business Summary 

    Uroplasty, Inc., a medical device company, develops, manufactures, and markets products for the treatment of voiding dysfunctions primarily in the United States. It principally offers Urgent PC Neuromodulation system, a minimally-invasive, neuromodulation system that delivers percutaneous tibial nerve stimulation for office-based treatment of overactive bladder and the associated symptoms of urinary urgency, urinary frequency, and urge incontinence. The company also provides Macroplastique implants, an injectable and urethral bulking agent for the treatment of adult female stress urinary incontinence due to intrinsic sphincter deficiency, as well as for the treatment of male stress incontinence, fecal incontinence, vocal cord rehabilitation, and vesicoureteral reflux. In addition, it offers Macroplastique products for treatment of vesicoureteral reflux; Urgent PC System for the treatment of fecal incontinence; PTQ Implants, which provides a minimally-invasive, soft-textured permanent implant for treatment of fecal incontinence; and VOX Implants, a silicone elastomer bulking material for vocal cord rehabilitation applications, as well as distributes wound care products. The company sells its products primarily to urologists, urogynecologists, and gynecologists through a direct sales organization in the United Kingdom, the Netherlands, Switzerland, and the Nordic countries, as well as through distributors in other markets. Uroplasty, Inc. was incorporated in 1992 and is headquartered in Minnetonka, Minnesota.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Uroplasty, Inc.

    Key Executives 
    Mr. Robert C.E. Kill , 51
    Chairman, Chief Exec. Officer and Pres
    Mr. Brett A. Reynolds Buch, 46
    Chief Financial Officer, Principal Accounting Officer, Sr. VP and Sec.
    Mr. Darin Hammers , 50
    Sr. VP of Global Sales and Marketing
    Mr. Marc M. Herregraven , 50
    VP of Operations
    Mr. Larry Heinemann , 63
    VP of Corp. Devel.
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders